JP2024507533A5 - - Google Patents
Info
- Publication number
- JP2024507533A5 JP2024507533A5 JP2023550277A JP2023550277A JP2024507533A5 JP 2024507533 A5 JP2024507533 A5 JP 2024507533A5 JP 2023550277 A JP2023550277 A JP 2023550277A JP 2023550277 A JP2023550277 A JP 2023550277A JP 2024507533 A5 JP2024507533 A5 JP 2024507533A5
- Authority
- JP
- Japan
- Prior art keywords
- rabies virus
- recombinant
- approximately
- functional variant
- genome
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163151542P | 2021-02-19 | 2021-02-19 | |
| US63/151,542 | 2021-02-19 | ||
| US202163241989P | 2021-09-08 | 2021-09-08 | |
| US63/241,989 | 2021-09-08 | ||
| PCT/US2022/017075 WO2022178307A1 (en) | 2021-02-19 | 2022-02-18 | Recombinant rabies viruses for gene therapy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024507533A JP2024507533A (ja) | 2024-02-20 |
| JP2024507533A5 true JP2024507533A5 (cg-RX-API-DMAC10.html) | 2025-02-26 |
Family
ID=80953580
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023550277A Pending JP2024507533A (ja) | 2021-02-19 | 2022-02-18 | 遺伝子治療のための組み換え狂犬病ウイルス |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20220290164A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4263825A1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2024507533A (cg-RX-API-DMAC10.html) |
| KR (1) | KR20230158476A (cg-RX-API-DMAC10.html) |
| AU (1) | AU2022224054A1 (cg-RX-API-DMAC10.html) |
| CA (1) | CA3208612A1 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2022178307A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3850088A4 (en) | 2018-09-07 | 2023-07-19 | Beam Therapeutics, Inc. | Compositions and methods for improving base editing |
| KR20210055733A (ko) | 2018-09-07 | 2021-05-17 | 빔 테라퓨틱스, 인크. | 핵염기 편집 시스템을 전달하기 위한 조성물 및 방법 |
| JP7646552B2 (ja) | 2019-01-31 | 2025-03-17 | ビーム セラピューティクス インク. | 低減された非標的脱アミノ化を有する核酸塩基エディターおよび核酸塩基エディターの特徴づけのためのアッセイ |
| US12600971B2 (en) | 2019-02-13 | 2026-04-14 | Beam Therapeutics Inc. | Modified immune cells having adenosine deaminase base editors for modifying a nucleobase in a target sequence |
| WO2020168135A1 (en) | 2019-02-13 | 2020-08-20 | Beam Therapeutics Inc. | Compositions and methods for treating alpha-1 antitrypsin deficiency |
| US12594301B2 (en) | 2019-09-27 | 2026-04-07 | Beam Therapeutics Inc. | Compositions and methods for treatment of liquid cancers |
| AU2021347359A1 (en) | 2020-09-25 | 2023-05-18 | Beam Therapeutics Inc. | Fratricide resistant modified immune cells and methods of using the same |
| CN118369429A (zh) * | 2021-09-08 | 2024-07-19 | 比姆医疗股份有限公司 | 病毒引导rna递送 |
| US20240327802A1 (en) * | 2023-02-01 | 2024-10-03 | Beam Therapeutics Inc. | Chimeric pseudotyped recombinant rabies virus |
| AU2024384487A1 (en) * | 2023-11-20 | 2026-06-04 | Beam Therapeutics Inc. | Compositions and methods for altering complement activation |
| CN119033805B (zh) * | 2024-08-12 | 2025-07-22 | 华南农业大学 | 靶向抑制狂犬病病毒G基因和/或L基因的siRNA在制备抑制狂犬病的药物中的应用 |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4880635B1 (en) | 1984-08-08 | 1996-07-02 | Liposome Company | Dehydrated liposomes |
| US4921757A (en) | 1985-04-26 | 1990-05-01 | Massachusetts Institute Of Technology | System for delayed and pulsed release of biologically active substances |
| US4920016A (en) | 1986-12-24 | 1990-04-24 | Linear Technology, Inc. | Liposomes with enhanced circulation time |
| JPH0825869B2 (ja) | 1987-02-09 | 1996-03-13 | 株式会社ビタミン研究所 | 抗腫瘍剤包埋リポソ−ム製剤 |
| US4917951A (en) | 1987-07-28 | 1990-04-17 | Micro-Pak, Inc. | Lipid vesicles formed of surfactants and steroids |
| US4911928A (en) | 1987-03-13 | 1990-03-27 | Micro-Pak, Inc. | Paucilamellar lipid vesicles |
| US6174666B1 (en) | 1992-03-27 | 2001-01-16 | The United States Of America As Represented By The Department Of Health And Human Services | Method of eliminating inhibitory/instability regions from mRNA |
| US6453242B1 (en) | 1999-01-12 | 2002-09-17 | Sangamo Biosciences, Inc. | Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites |
| US6534261B1 (en) | 1999-01-12 | 2003-03-18 | Sangamo Biosciences, Inc. | Regulation of endogenous gene expression in cells using zinc finger proteins |
| US7013219B2 (en) | 1999-01-12 | 2006-03-14 | Sangamo Biosciences, Inc. | Regulation of endogenous gene expression in cells using zinc finger proteins |
| US6503717B2 (en) | 1999-12-06 | 2003-01-07 | Sangamo Biosciences, Inc. | Methods of using randomized libraries of zinc finger proteins for the identification of gene function |
| US6599692B1 (en) | 1999-09-14 | 2003-07-29 | Sangamo Bioscience, Inc. | Functional genomics using zinc finger proteins |
| JP2003514564A (ja) | 1999-11-24 | 2003-04-22 | エムシーエス マイクロ キャリア システムズ ゲーエムベーハー | 核局在化シグナルまたはタンパク質導入領域の多量体を含むポリペプチド、および分子を細胞内へ移入するためのその使用法 |
| AU2001250774B2 (en) | 2000-02-08 | 2005-01-27 | Sangamo Biosciences, Inc. | Cells expressing zinc finger proteins for drug discovery |
| EP1434862A4 (en) * | 2001-07-20 | 2005-04-06 | Univ Georgia Res Found | ATTENUATED TOLL WUTVIRUS WITH NUCLEOPROTEIN MUTATION AT THE PHOSPHORYLATION CENTER FOR VACCINATION AGAINST FOLLOW-UP AND GENE THERAPY IN THE CNS |
| HUE041426T2 (hu) | 2009-11-02 | 2019-05-28 | Univ Washington | Terápiás nukleáz-készítmények és eljárások |
| WO2011163446A2 (en) * | 2010-06-24 | 2011-12-29 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention | Pan-lyssavirus vaccines against rabies |
| WO2012106490A1 (en) * | 2011-02-03 | 2012-08-09 | The Government Of The U.S.A., As Represented By The Secretary, Department Of Health & Human Services | Multivalent vaccines for rabies virus and filoviruses |
| PL3346983T3 (pl) | 2015-09-11 | 2020-11-16 | Wm. Wrigley Jr. Company | Synergistyczne działanie przeciwbakteryjne ekstraktu kory magnolii i L-argininy, estru N-alfa-etylowo-lauroilowego na bakterie występujące w ślinie |
| CN105139759B (zh) | 2015-09-18 | 2017-10-10 | 京东方科技集团股份有限公司 | 一种拼接屏 |
| WO2017070632A2 (en) | 2015-10-23 | 2017-04-27 | President And Fellows Of Harvard College | Nucleobase editors and uses thereof |
| WO2017200790A1 (en) * | 2016-05-20 | 2017-11-23 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Real-time reverse transcriptase-polymerase chain reaction assay with modified probe for the diagnosis of rabies viruses and other lyssaviruses |
| WO2018027078A1 (en) | 2016-08-03 | 2018-02-08 | President And Fellows Of Harard College | Adenosine nucleobase editors and uses thereof |
| GB201706945D0 (en) * | 2017-05-02 | 2017-06-14 | Medical Res Council | Self-inactivating viral vector |
| WO2019013258A1 (ja) * | 2017-07-11 | 2019-01-17 | 国立大学法人 東京大学 | 光制御性のウイルスタンパク質、その遺伝子、及びその遺伝子を含むウイルスベクター |
| CN109929839B (zh) * | 2017-12-18 | 2021-02-12 | 华东师范大学 | 拆分型单碱基基因编辑系统及其应用 |
| US11453893B2 (en) * | 2018-08-30 | 2022-09-27 | California Institute Of Technology | RNA-based delivery systems with levels of control |
-
2022
- 2022-02-18 JP JP2023550277A patent/JP2024507533A/ja active Pending
- 2022-02-18 CA CA3208612A patent/CA3208612A1/en active Pending
- 2022-02-18 AU AU2022224054A patent/AU2022224054A1/en active Pending
- 2022-02-18 EP EP22713480.6A patent/EP4263825A1/en active Pending
- 2022-02-18 US US17/651,738 patent/US20220290164A1/en active Pending
- 2022-02-18 KR KR1020237029781A patent/KR20230158476A/ko active Pending
- 2022-02-18 WO PCT/US2022/017075 patent/WO2022178307A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3684925B1 (en) | Non-integrating dna vectors for the genetic modification of cells | |
| AU760770B2 (en) | Episomally relicating vector, its preparation and use | |
| Liu et al. | Cationic Liposome-mediated Intravenous Gene Delivery (∗) | |
| DE69429260T2 (de) | Adenovirale vektoren tierischen ursprungs und ihre verwendung bei der gentherapie | |
| Mulia et al. | Advances in the development and the applications of nonviral, episomal vectors for gene therapy | |
| Ohwada et al. | Regional delivery of an adenovirus vector containing the Escherichia coli cytosine deaminase gene to provide local activation of 5-fluorocytosine to suppress the growth of colon carcinoma metastatic to liver | |
| Zeng et al. | High-efficiency stable gene transfer of adenovirus into mammalian cells using ionizing radiation | |
| NZ315295A (en) | Ovine adenovirus oav287 and its use in gene therapy | |
| US6881724B2 (en) | Use of magnesium (Mg2+) for the preparation of a therapeutic composition for transfection of a polynucleotide into a cell and compositions useful in gene therapy | |
| JP2024533396A5 (cg-RX-API-DMAC10.html) | ||
| Acsadi et al. | Interferons impair early transgene expression by adenovirus-mediated gene transfer in muscle cells | |
| Kaneda | Improvements in gene therapy technologies | |
| JP2026513742A (ja) | 合成回路及びその使用 | |
| JPH02502605A (ja) | 遺伝子発現の刺激方法 | |
| US20020142393A1 (en) | Episomally replicating vector, its preparation and use | |
| DE69810925T2 (de) | Verwendung eines kationischen Polymer zur Herstellung von Nukleinsäure-Komplexe und verwandte Zusammensetzungen | |
| Narumi et al. | Adenovirus vector-mediated perforin expression driven by a glucocorticoid-inducible promoter inhibits tumor growth in vivo | |
| US6723708B2 (en) | Use of lithium (Li+) for the preparation of a composition for transfection of a polynucleotide into a cell and compositions useful in gene therapy | |
| Bogomolova et al. | Genetic engineering approaches to the development of modern therapeutics | |
| HK40031637B (en) | Non-integrating dna vectors for the genetic modification of cells | |
| HK40031637A (en) | Non-integrating dna vectors for the genetic modification of cells | |
| Lund | Journal of Experimental Biochemistry & Physiology | |
| HK40060164A (en) | Rna site-directed editing using artificially constructed rna editing enzymes and related uses | |
| Wang et al. | 465. In Vivo Selection of Genetically Modified Primary Human Hematopoietic Cells Using a Cell Growth Switch | |
| KANEDA | DEVELOPMENT OF HVJ-LIPOSOMES AND CANCER GENE THERAPY |